Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib

We report the case of a 56-year-old man with chronic myeloid leukemia (CML) who developed dasatinib-induced interstitial lung disease (ILD) 7 years after starting dasatinib, a BCR-ABL1 inhibitor. The patient presented with dyspnea. Chest imaging showed diffuse ground-glass opacities. A surgical lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Takekoshi, Daisuke, Matsui, Yuma, Akutsu, Takuya, Nishioka, Ayako, Kiritani, Ayu, Okuda, Keitaro, Watanabe, Junko, Miyagawa, Hanae, Utsumi, Hirohumi, Hashimoto, Mitsuo, Wakui, Hiroshi, Minagawa, Shunsuke, Hara, Hiromichi, Numata, Takanori, Noda, Yuki, Makishima, Rei, Ikegami, Masahiro, Kawabata, Yoshinori, Araya, Jun, Kuwano, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578610/
https://www.ncbi.nlm.nih.gov/pubmed/32536651
http://dx.doi.org/10.2169/internalmedicine.4714-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578610/
https://www.ncbi.nlm.nih.gov/pubmed/32536651
http://dx.doi.org/10.2169/internalmedicine.4714-20

Ejemplares similares